The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients.
The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold or perhaps give companies lead time to substitute other ingredients.
Does anyone know if phenylephrine is otherwise harmless? If it’s essentially harmless, and assuming all these various products have other ingredients that remain effective, then it seems to me that the easiest thing for the companies to do is to move phenylephrine from the “active ingredients” section to the “inactive ingredients” section.